Ono Pharmaceutical Co., Ltd. (TSE:4528) announces a share repurchase program. Under the program, the company will repurchase up to 19,000,000 shares, representing 3.89% of its issued share capital, for ¥50,000 million. The purpose of the program is to improve capital efficiency in consideration of financial and stock price conditions and implement it as part of our comprehensive shareholder return policy.

All repurchased shares will be cancelled. The program will continue through March 22, 2024. As of March 31, 2023, the company had 488,399,246 issued shares (excluding treasury stock) and 29,025,954 treasury shares.